CALR and leukemia: In turn, these innate immune cells become capable of priming antigen-specific T cell responses directed against malignant cells, termed “immunologic cell death.” Elevated cell surface CRT expression has also been observed on viable malignant cells – including leukemia blasts (45, 46), suggesting that cell death may not be a prerequisite for CRT translocation.